Effects Of CP-690,550 (Tasocitinib) On Cholesterol Metabolism In Patients With Active Rheumatoid Arthritis
Clinical trial NCT01262118 · COMPLETED
Trial details
- NCT number
- NCT01262118
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-01
- Primary completion
- 2012-01-01
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.